Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Treatments for hair loss vary, but cell-based options may be the future.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Two-photon microscopy helps observe hair follicle stem cell behaviors in mice.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

No link found between new male baldness genes and female hair loss.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Targeting the actin cytoskeleton could improve skin healing and reduce scarring.

Possible link between androgens and COVID-19 severity; more research needed.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Finasteride may lower cholesterol and slow heart disease progression.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.